tiprankstipranks
Trending News
More News >
Neurogene announces treatment intended to reverse HLH
PremiumThe FlyNeurogene announces treatment intended to reverse HLH
22d ago
Cautious Hold Rating on Neurogene Due to Regulatory Uncertainty and Data Quality Concerns for NGN-401
Premium
Ratings
Cautious Hold Rating on Neurogene Due to Regulatory Uncertainty and Data Quality Concerns for NGN-401
23d ago
Neurogene downgraded to Neutral from Outperform at Baird
Premium
The Fly
Neurogene downgraded to Neutral from Outperform at Baird
23d ago
Neurogene Reports Q1 2025 Financial Results and Advances Rett Syndrome Gene Therapy
PremiumCompany AnnouncementsNeurogene Reports Q1 2025 Financial Results and Advances Rett Syndrome Gene Therapy
29d ago
Promising Outlook for Neurogene: Strategic Advancements and Regulatory Prospects Justify Buy Rating
Premium
Ratings
Promising Outlook for Neurogene: Strategic Advancements and Regulatory Prospects Justify Buy Rating
29d ago
NGNE Upcoming Earnings Report: What to Expect?
Premium
Pre-Earnings
NGNE Upcoming Earnings Report: What to Expect?
1M ago
BMO says Peter Marks resignation ‘significant negative’ for biotech
PremiumThe FlyBMO says Peter Marks resignation ‘significant negative’ for biotech
2M ago
Neurogene’s Promising Outlook: Buy Rating Backed by Robust Financials and Upcoming Clinical Milestones
Premium
Ratings
Neurogene’s Promising Outlook: Buy Rating Backed by Robust Financials and Upcoming Clinical Milestones
2M ago
Neurogene Reports 2024 Financial Results and Advances in Rett Syndrome Trial
Premium
Company Announcements
Neurogene Reports 2024 Financial Results and Advances in Rett Syndrome Trial
2M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100